BDRX logo

Biodexa Pharmaceuticals (BDRX)

Profile

Full Name

Biodexa Pharmaceuticals Plc

Ticker Symbol

BDRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

December 7, 2015

Indexes

Not included

Website

http://www.biodexapharma.com

Employees

21

Key Details

Price

$1.46(-11.52%)

Market cap

$976.16K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$474.10K(-45.23% YoY)

Annual EPS

-$248.86(+98.70% YoY)

PE ratio

-

Next earnings date

Apr 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.46
BDRX price is $1.46

30-Day Relative Volume

0.11
BDRX 30-day relative volume is 0.11

Price Performance

Price Most recent change

-11.52%
BDRX price was down -11.52% on Apr 15, 2025

Price YTD change

-63.95%
BDRX price is down -63.95% since January 1st

Price 1-year change

-93.22%
BDRX price is down -93.22% year-on-year

Price 3-year change

-100%
BDRX price is down -100% over the past 3 years

Price Range

Price All-time high

$14700000.00
BDRX price is currently -100.00% below its historical high of $14700000.00

Price 3-year low

$0.35
BDRX price is currently +313.60% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$976.16K
BDRX market capitalization is $976.16 thousand

Market cap 3-year change

-94.32%
BDRX market capitalization is down -94.32% over the past 3 years

Market cap All-time high

$51.40M
BDRX market capitalization is currently -98.10% below its historical high of $51.40 million

Market cap sector rank

4.11%
BDRX market capitalization is higher than 4.11% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+281.19%
BDRX shares outstanding is up +281.19% year-on-year

Shares Outstanding 3-Year Change

+133620%
BDRX shares outstanding is up +133620% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.20
BDRX beta is 1.20

200-day SMA

$7.82
BDRX price is currently -81.33% below its 200-day simple moving average

50-day SMA

$2.72
BDRX price is currently -46.35% below its 50-day simple moving average

RSI

39.31
BDRX 14-day relative strength index is 39.31

Volume

0.11
BDRX 30-day relative volume is 0.11

ATR

$0.32
BDRX average true range is $0.32

10-day Historical Volatility

211.46%
BDRX 10-day historical volatility is 211.46%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$474.10K
BDRX annual revenue is $474.10 thousand

Revenue Analysts estimate

-
BDRX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-45.23%
BDRX annual revenue is down -45.23% year-on-year

Revenue Sector rank

9.61%
BDRX annual revenue is higher than 9.61% of companies in Healthcare sector

EPS

EPS

-$248.86
BDRX annual earnings per share is -$248.86

EPS Analysts estimate

-$0.05
BDRX annual earnings per share is currently >+9900.00% higher than the consensus analysts' forecast

EPS 1-year change

+98.7%
BDRX annual earnings per share is up +98.7% year-on-year

EPS Sector rank

0.99%
BDRX annual earnings per share is higher than 0.99% of companies in Healthcare sector

Profit

Gross profit

-$4.59M
BDRX annual gross profit is -$4.59 million

Gross margin

-967.45%
BDRX annual gross profit margin is -967.45%

Operating profit

-$9.97M
BDRX annual operating income is -$9.97 million

Operating margin

-2103.41%
BDRX annual operating profit margin is -2103.41%

Net income

-$8.81M
BDRX annual net profit is -$8.81 million

Net margin

-1858.01%
BDRX annual net profit margin is -1858.01%

Expenses

Total expenses

$10.45M
BDRX annual total expenses is $10.45 million

Operating expenses

$5.39M
BDRX annual total operating expenses is $5.39 million

Cost of goods sold

$5.06M
BDRX annual cost of goods sold is $5.06 million

Selling, general & administrative expenses

$5.40M
BDRX annual SGA is $5.40 million

Depreciation and amortization

$352.10K
BDRX annual depreciation & amortization is $352.10 thousand

Interest expense

$51.00K
BDRX annual interest expense is $51.00 thousand

Income tax

-$505.20K
BDRX annual income tax is -$505.20 thousand

EBIT & EBITDA

EBIT

-$9.26M
BDRX annual earnings before interest & taxes is -$9.26 million

EBITDA

-$8.91M
BDRX annual EBITDA is -$8.91 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$13.43M
BDRX annual total assets is $13.43 million

Non current assets

$4.47M
BDRX annual long term assets is $4.47 million

Current assets

$8.96M
BDRX annual total current assets is $8.96 million

Cash and cash equivalents

$7.61M
BDRX annual cash & cash equivalents is $7.61 million

Accounts receivable

$0.00
BDRX annual accounts receivable is $0.00

Inventory

-
BDRX annual inventory value is unknown

Liabilities

Total liabilities

$7.47M
BDRX annual total liabilities is $7.47 million

Long term liabilities

$375.80K
BDRX annual total long term liabilities is $375.80 thousand

Current liabilities

$7.09M
BDRX annual total current liabilities is $7.09 million

Accounts payable

$400.00K
BDRX annual accounts payable is $400.00 thousand

Debt

Total debt

$591.10K
BDRX annual total debt is $591.10 thousand

Total debt 1-year change

-21.72%
BDRX annual total debt is down -21.72% year-on-year

Long term debt

$375.80K
BDRX annual long term debt is $375.80 thousand

Short term debt

$215.30K
BDRX annual short term debt is $215.30 thousand

Equity & Capital

Shareholders equity

$5.96M
BDRX annual stockholders equity is $5.96 million

Book value

$5.96M
BDRX annual book value is $5.96 million

Retained earnings

-$184.42M
BDRX annual retained earnings is -$184.42 million

Working capital

$1.86M
BDRX annual working capital is $1.86 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.49M
BDRX annual cash flow from operations is -$8.49 million

Cash from operations 1-year change

+2.68%
BDRX annual cash flow from operations is up +2.68% year-on-year

Cash from investing

-$329.70K
BDRX annual cash flow from investing activities is -$329.70 thousand

Cash from investing 1-year change

-21.04%
BDRX annual cash flow from investing activities is down -21.04% year-on-year

Cash from financing

$12.72M
BDRX annual cash flow from financing activities is $12.72 million

Cash from financing 1-year change

+21763.23%
BDRX annual cash flow from financing activities is up +21763.23% year-on-year

CAPEX

CAPEX

$327.30K
BDRX annual capital expenditures is $327.30 thousand

CAPEX 1-year change

+326.17%
BDRX annual capital expenditures is up +326.17% year-on-year

Free Cash Flow

Free cash flow

-$8.82M
BDRX annual free cash flow is -$8.82 million

Free cash flow 1-year change

-0.19%
BDRX annual free cash flow is down -0.19% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-967.45%
BDRX annual gross profit margin is -967.45%

Operating margin

-2103.41%
BDRX annual operating profit margin is -2103.41%

Net margin

-1858.01%
BDRX annual net profit margin is -1858.01%

ROA & ROE

ROA

-87.58%
BDRX annual return on assets is -87.58%

ROE

-180.02%
BDRX annual return on equity is -180.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BDRX price to earnings ratio value is unknown

PE ratio Sector rank

-
BDRX price to earnings ratio is unknown

PB Ratio

PB ratio

0.09
BDRX price to book ratio is 0.09

PB ratio Sector rank

17.94%
BDRX price to book ratio is higher than 17.94% of companies in Healthcare sector

PS Ratio

PS ratio

-
BDRX price to sales ratio value is unknown

PS ratio Sector rank

-
BDRX price to sales ratio is unknown

Enterprise value

Enterprise value

-$4.93M
BDRX enterprise value is -$4.93 million

Enterprise value Sector rank

6.7%
BDRX enterprise value is higher than 6.7% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
BDRX EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
BDRX EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.26
BDRX annual current ratio is 1.26

Quick ratio

-
BDRX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
BDRX annual debt to equity ratio is 0.00

Interest coverage ratio

-181.62
BDRX annual interest coverage ratio is -181.62

Risk & Stability

Piotroski F-Score

-
BDRX piotroski f-score value is unknown

Altman Z-Score

-21.22
BDRX altman z-score is -21.22

Analyst ratings

Recent major analysts updates

Feb 8, 24 Ladenburg Thalmann
Buy

Institutional Ownership

Similar stocks

DYNT logo
Dynatronics (DYNT)
TRVN logo
Trevena (TRVN)
BIOR logo
Biora Therapeutics (BIOR)
APDN logo
Applied DNA Sciences (APDN)
NEPT logo
Neptune Wellness Solutions (NEPT)
WINT logo
Windtree Therapeutics (WINT)
AFIB logo
Acutus Medical (AFIB)
NAYA Biosciences (NAYA)
ATXI logo
Avenue Therapeutics (ATXI)
  • What is the ticker symbol for Biodexa Pharmaceuticals?
  • Does Biodexa Pharmaceuticals pay dividends?
  • What sector is Biodexa Pharmaceuticals in?
  • What industry is Biodexa Pharmaceuticals in?
  • What country is Biodexa Pharmaceuticals based in?
  • When did Biodexa Pharmaceuticals go public?
  • Is Biodexa Pharmaceuticals in the S&P 500?
  • Is Biodexa Pharmaceuticals in the NASDAQ 100?
  • Is Biodexa Pharmaceuticals in the Dow Jones?
  • When was Biodexa Pharmaceuticals's last earnings report?
  • When does Biodexa Pharmaceuticals report earnings?

What is the ticker symbol for Biodexa Pharmaceuticals?

The ticker symbol for Biodexa Pharmaceuticals is NASDAQ:BDRX

Does Biodexa Pharmaceuticals pay dividends?

No, Biodexa Pharmaceuticals does not pay dividends

What sector is Biodexa Pharmaceuticals in?

Biodexa Pharmaceuticals is in the Healthcare sector

What industry is Biodexa Pharmaceuticals in?

Biodexa Pharmaceuticals is in the Biotechnology industry

What country is Biodexa Pharmaceuticals based in?

Biodexa Pharmaceuticals is headquartered in United Kingdom

When did Biodexa Pharmaceuticals go public?

Biodexa Pharmaceuticals's initial public offering (IPO) was on December 7, 2015

Is Biodexa Pharmaceuticals in the S&P 500?

No, Biodexa Pharmaceuticals is not included in the S&P 500 index

Is Biodexa Pharmaceuticals in the NASDAQ 100?

No, Biodexa Pharmaceuticals is not included in the NASDAQ 100 index

Is Biodexa Pharmaceuticals in the Dow Jones?

No, Biodexa Pharmaceuticals is not included in the Dow Jones index

When was Biodexa Pharmaceuticals's last earnings report?

Biodexa Pharmaceuticals's most recent earnings report was on Apr 19, 2024

When does Biodexa Pharmaceuticals report earnings?

The next expected earnings date for Biodexa Pharmaceuticals is Apr 18, 2025
On this page